Literature DB >> 9298732

Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralizing antibody responses in early patient sera.

A Lundkvist1, M Hukic, J Hörling, M Gilljam, S Nichol, B Niklasson.   

Abstract

Hantavirus infection was diagnosed serologically by mu-capture IgM and IgG ELISAs in hemorrhagic fever with renal syndrome (HFRS) patients admitted to Tuzla Hospital, Bosnia-Herzegovina. The results indicated that more than one hantavirus caused the outbreak. To address the question of which hantavirus serotypes were involved, sequentially drawn sera were analyzed by focus reduction neutralization test (FRNT) for antibodies against Puumala, Hantaan, Dobrava, and Seoul hantaviruses. The data revealed that acute- or early convalescent-phase sera, even when drawn as late as 3 weeks after the onset of disease, could not be used for typing of the causative hantavirus; a significant number of these samples showed similar reactivity of neutralizing antibodies to several different hantavirus serotypes. Moreover, although several acute-phase sera showed the highest FRNT titer to Hantaan virus, convalescent sera from these patients in all cases showed high specificity for Puumala or Dobrava viruses. This phenomenon, interpreted as a cross-neutralizing primary antibody response, makes several earlier reports concerning causative agents of HFRS questionable. Serological examination of small rodents trapped in the endemic area identified Puumala- and Dobrava-like virus infections. RT-PCR and sequencing of rodent lung samples identified Dobrava virus in one yellow-necked field mouse (Apodemus flavicollis). Cross-FRNT data, using polyclonal rabbit antibodies, clearly confirmed Dobrava virus as a unique hantavirus serotype. In conclusion, the results revealed that both Puumala- and Dobrava-like viruses caused HFRS in Bosnia-Herzegovina, whereas no signs of Hantaan or Seoul virus involvement were found.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298732

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  38 in total

1.  Diagnostic potential of puumala virus nucleocapsid protein expressed in Drosophila melanogaster cells.

Authors:  K Brus Sjölander; I Golovljova; A Plyusnin; A Lundkvist
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Pathogenicity and virulence of the present hantaviruses in Bosnia and Herzegovina: the impact on renal function.

Authors:  M Hukić; A Valjevac; D Tulumovic; F Numanovic; P Heyman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-23       Impact factor: 3.267

3.  Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins.

Authors:  Helga Meisel; Anne Wolbert; Ausra Razanskiene; Andreas Marg; Andris Kazaks; Kestutis Sasnauskas; Georg Pauli; Rainer Ulrich; Detlev H Krüger
Journal:  Clin Vaccine Immunol       Date:  2006-10-04

4.  Central European Dobrava Hantavirus isolate from a striped field mouse (Apodemus agrarius).

Authors:  Boris Klempa; Michal Stanko; Milan Labuda; Rainer Ulrich; Helga Meisel; Detlev H Krüger
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 5.  Hantavirus infections in Greece--an update.

Authors:  A Papa; A Antoniadis
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 6.  A global perspective on hantavirus ecology, epidemiology, and disease.

Authors:  Colleen B Jonsson; Luiz Tadeu Moraes Figueiredo; Olli Vapalahti
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

7.  New immunochromatographic rapid test for diagnosis of acute Puumala virus infection.

Authors:  H Hujakka; V Koistinen; P Eerikäinen; I Kuronen; I Mononen; M Parviainen; A Vaheri; A Närvänen; O Vapalahti
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

8.  Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses.

Authors:  Sabine Lederer; Erik Lattwein; Merle Hanke; Karen Sonnenberg; Winfried Stoecker; Åke Lundkvist; Antti Vaheri; Olli Vapalahti; Paul K S Chan; Heinz Feldmann; Daryl Dick; Jonas Schmidt-Chanasit; Paula Padula; Pablo A Vial; Raluca Panculescu-Gatej; Cornelia Ceianu; Paul Heyman; Tatjana Avšič-Županc; Matthias Niedrig
Journal:  PLoS Negl Trop Dis       Date:  2013-04-04

9.  Human puumala and dobrava hantavirus infections in the Black Sea region of Turkey: a cross-sectional study.

Authors:  Aysegul Gozalan; Handan Kalaycioglu; Yavuz Uyar; Demet Furkan Sevindi; Bedia Turkyilmaz; Vedat Çakir; Cengiz Cindemir; Belgin Unal; Dilek Yağçi-Çağlayik; Gulay Korukluoglu; Mustafa Ertek; Paul Heyman; Åke Lundkvist
Journal:  Vector Borne Zoonotic Dis       Date:  2013-01-05       Impact factor: 2.133

10.  Dobrava virus carried by the yellow-necked field mouse Apodemus flavicollis, causing hemorrhagic fever with renal syndrome in Romania.

Authors:  Raluca Ioana Panculescu-Gatej; Anca Sirbu; Sorin Dinu; Maria Waldstrom; Paul Heyman; Dimitru Murariu; Angela Petrescu; Camelia Szmal; Gabriela Oprisan; Ake Lundkvist; Cornelia S Ceianu
Journal:  Vector Borne Zoonotic Dis       Date:  2014-04-18       Impact factor: 2.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.